Clinical outcome of Crohn's disease treated with infliximab

Arslan S., Kav T., Besisik F., Kaymakoglu S., Pinarbasi B., Tozun N., ...Daha Fazla

HEPATO-GASTROENTEROLOGY, cilt.50, sa.52, ss.952-956, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 52
  • Basım Tarihi: 2003
  • Dergi Adı: HEPATO-GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.952-956
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

Background/Aims: Controlled studies in humans have shown the role of antibodies to tumor necrosis factor-alpha in the treatment of both fistulizing and inflammatory Crohn's disease. The aim of this study is to report the results of a multicenter clinical trial to evaluate efficacy of infliximab in Crohn's disease patients who are refractory to conservative drugs or fistulizing Crohn's disease.